Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease – New England Journal of Medicine Commentaries: Inhaled Treprostinil Beneficial in Pulmonary Hypertension – HealthDay   Commentary on Twitter Patients with pulmonary hypertension due to interstitial lung disease were randomly assigned to inhale treprostinil or placebo. At 16 weeks, there was a significant improvement in […]

The post Randomized trial: Inhaled Treprostinil in pulmonary hypertension due to interstitial lung disease appeared first on Links Medicus.